v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 7,746 $ 20,964
Adjustments to reconcile net income to net cash from operations provided by operating activities:    
Amortization of patent formulations 2,187 1,742
Amortization of other intangibles 11,289 10,323
Inventory write-off and disposal 863 2,610
Depreciation of fixed assets 149 116
Amortization of debt issuance costs 453 453
Deferred taxes (231) 847
Share-based compensation expense 3,183 2,018
Other operating 265 265
Changes in operating assets and liabilities:    
Accounts receivable, net 15,114 704
Inventory 552 10,407
Other current assets 1,507 (7,108)
Accounts payable 9,553 (340)
Accrued expenses, sales tax and income tax payable (6,929) 5,116
Other assets and liabilities (1,994) (28)
Net cash provided by operating activities 43,707 48,089
Cash flows from investing activities:    
Purchase of property and equipment (451) (107)
Purchase of software (633) (524)
Net cash used in investing activities (1,084) (631)
Cash flows from financing activities:    
Proceeds from exercise of stock options 171 2,513
Payments related to shares withheld and retired to cover tax withholding obligation for SARs 0 (64)
Principal payments of Term Loan (1,688) (3,375)
Net cash used in financing activities (1,517) (926)
Net increase in cash and cash equivalents 41,106 46,532
Cash and cash equivalents - beginning of period 466,400 322,808
Cash and cash equivalents - end of period 507,506 369,340
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 4,998 91
Cash paid during the year for interest 14,990 13,853
Supplemental disclosure of noncash activities:    
Assets acquired under operating lease 742 0
Increase in related party payable related to the tax receivable agreement 587 0
Property and equipment non cash transaction $ 9 $ 0

Source

PDF